Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
A randomized controlled trial comparing two ways of providing evidence-based drug information to GPs
Department of Public Health and Community Medicine/Primary Health Care, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden; Research and Development Unit, Primary Health Care and Dental Care, Southern Älvsborg County, Region Västra Götaland, Vänersborg, Sweden.
Department of Public Health and Community Medicine/Primary Health Care, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden.
Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Cairns Clinical School, School of Medicine and Dentistry, James Cook University, Douglas QLD, Australia.
Show others and affiliations
2013 (English)In: Scandinavian Journal of Primary Health Care, ISSN 0281-3432, E-ISSN 1502-7724, Vol. 31, no 2, p. 67-72Article in journal (Refereed) Published
Abstract [en]

Objective. To investigate whether tailored evidence-based drug information (EBDI) to general practitioners (GPs) can change the proportion of ACE inhibitor prescriptions more effectively than EBDI provided as usual three and six months after the intervention.

Design. Randomized controlled trial.

Setting. GPs in southern Sweden working at primary health care centres (PHCCs) in seven drug and therapeutic committee areas.

Intervention. EBDI tailored to motivational interviewing (MI) technique and focused on the benefit aspect was compared with EBDI provided as usual.

Subjects. There were 408 GPs in the intervention group and 583 GPs in the control group.

Main outcome measures. Change in proportion of ACE inhibitor prescriptions relative to the sum of ACE inhibitors and angiotensin receptor blockers, three and six months after the intervention.

Results. The GPs' average proportions of prescribed ACE inhibitors increased in both groups. No statistically significant differences in the change of proportions were found between intervention and control groups. Information was provided to 29% of GPs in both groups.

Conclusion. This study could not prove that specially tailored EBDI using MI implements guidelines more effectively than EBDI provided as usual.

Place, publisher, year, edition, pages
2013. Vol. 31, no 2, p. 67-72
Keywords [en]
Benefit aspects, drug information services, drug prescriptions, evidence-based medicine, general practice, general practitioner, motivational interviewing, primary health care, Sweden
National Category
Medical and Health Sciences
Research subject
Medicine
Identifiers
URN: urn:nbn:se:oru:diva-29602DOI: 10.3109/02813432.2012.757071ISI: 000318643200002OAI: oai:DiVA.org:oru-29602DiVA, id: diva2:629583
Available from: 2013-06-17 Created: 2013-06-17 Last updated: 2018-09-12Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full text

Search in DiVA

By author/editor
Möller, Margareta
By organisation
School of Health and Medical Sciences, Örebro University, Sweden
In the same journal
Scandinavian Journal of Primary Health Care
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 460 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf